Erectile Dysfunction and Methadone Maintenance Therapy
Erectile Dysfunction and Methadone Maintenance Therapy
Vol. 15 No. 1 : 2020 (5-17)
Abstract
Erectile dysfunction is one of the most common side effects of methadone affecting more than half of methadone patient population. The problem is associated with prominent reduced quality of life. Erectile dysfunction may perpetuate greater problem if left untreated as patients may opt to use harmful self-treatment such as abusing methamphetamine. This illicit drug use to overcome the side-effects of methadone may lead to polysubstance use disorder that further compromise addiction therapy. To overcome this issue, both practitioners and patients play a major role in the management of erectile dysfunction. Patient awareness regarding erectile dysfunction and its impact as well as doctor’s active intervention to detect erectile dysfunction, are essential to improve the detection rate and management of erectile dysfunction. Frequent screening of erectile dysfunction and its risk factors will help with the identification of patients suffering from erectile dysfunction. Multiple treatments options such as bupropion, trazodone and many more are available to treat erectile dysfunction which will be further explored in this review.
Keywords :
erectile dysfunction,
methadone,
opioid-related disorder,
Correspondance Address
Isa Naina Mohamed. Pharmacoepidemiology and Drug Safety Unit, Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia. Tel: +603-9145 9545 Email: isanaina@ppukm.ukm.edu.my
References
Ab Rahman, A.A., Al-Sadat, N., Yun Low, W. 2011. Help seeking behaviour among men with erectile dysfunction in primary care setting. J Mens Health 8(S1): S94-S96.
Adams, M.L., Sewing, B.R.Y.A.N., Forman, J.B., Meyer, E.R., Cicero, T.J. 1993. Opioid-induced suppression of rat testicular function. J Pharmacol Exp Ther 266(1): 323-8.
Ahn, T.Y., Lee, D.S., Hong, J.H., Kim, Y.S. 2001. Validation of an abridged Korean version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Korean J Urol 42(5): 535-40.
Akkus, E., Kadioglu, A., Esen, A., Doran, S., Ergen, A., Anafarta, K., Hattat, H., Turkish Erectile Dysfunction Prevalence Study, G. 2002. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol 41(3): 298-304.
Andersson, K.E., Wagner, G. 1995. Physiology of penile erection. Physiol Rev 75(1): 191-236.
Babakhanian, M., Alam Mehrjerdi, Z., Shenaiy, Y. 2012. Sexual dysfunction in male crystalline heroin dependents before and after MMT: a pilot study. Arch Iran Med 15(12): 751-5.
Bawor, M., Dennis, B., Samaan, M., Plater, C., Worster, A., Varenbut, M., Daiter, J., Marsh, D.C., Desai, D., Steiner, M., Anglin, R., Coote, M., Pare, G., Thabane, L., Samaan, Z. 2015. Methadone induces testosterone suppression in patients with opioid addiction. Sci Rep 4: 6189.
Blick, G., Khera, M., Bhattacharya, R.K., Nguyen, D., Kushner, H., Miner, M.M. 2012.Testosterone replacement therapy outcomes among opioid users: The Testim Registry in the United States (TRIUS). Pain Med 13(5): 688-98.
Bliesener, N., Albrecht, S., Schwager, A., Weckbecker, K., Lichtermann, D., Klingmuller, D. 2005. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 90(1): 203-6.
Blumentals, W.A., Brown, R.R., Gomez-Caminero, A. 2003. Antihypertensive treatment and erectile dysfunction in a cohort of type II diabetes patients. Int J Impot Res 15(5): 314-7.
Bolona, E.R., Uraga, M.V., Haddad, R.M., Tracz, M.J., Sideras, K., Kennedy, C.C., Caples, S.M., Erwin, P.J., Montori, V.M. 2007. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 82(1): 20-8.
Boskabady, M.H., Shafei, M.N., Saberi, Z., Amini, S. 2011. Pharmacological effects of rosa damascena. Iran J Basic Med Sci 14(4): 295-307.
Brogden, R.N., Heel, R.C., Speight, T.M., Avery, G.S. 1981. Trazodone: A review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs 21(6): 401-29.
Brown, R., Balousek, S., Mundt, M., Fleming, M. 2005. Methadone maintenance and male sexual dysfunction. J Addicti Dis 24(2): 91-106.
Cappelleri, J.C., Rosen, R.C., Smith, M.D., Mishra, A., Osterloh, I.H. 1999. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 54(2): 346-51.
Cheng, C.M., Lin, Y.C., Chang, K.C. 2017. Psychological distress is correlated with erectile dysfunction among patients receiving methadone maintenance in Taiwan. J Dual Diagn 13(4): 312-6.
Cicero, T.J., Meyer, E.R., Bell, R.D., Koch, G.A. 1976. Effects of morphine and methadone on serum testosterone and luteinizing hormone levels and on the secondary sex organs of the male rat. Endocrinology 98(2): 367-72.
Cioe, P.A., Friedmann, P.D., Stein, M.D. 2010. Erectile dysfunction in opioid users: lack of association with serum testosterone. J Addict Dis 29(4): 455-60.
Dhir, A., Kulkarni, S.K. 2007. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol 568(1-3): 177-85.
Farnia, V., Tatari, F., Alikhani, M., Shakeri, J., Taghizadeh, M., Karbasizadeh, H., Bahmani, D. S., Holsboer-Trachsler, E., Brand, S. 2017. Rosa Damascena oil improved sexual function and testosterone in male patients with opium use disorder under methadone maintenance therapy–results from a double-blind, randomized, placebo-controlled clinical trial. Drug Alcohol Depend 176: 117-25.
Fink, H. A., Macdonald, R., Rutks, I. R., Wilt, T. J. 2003. Trazodone for erectile dysfunction: a systematic review and meta-analysis. BJU Int 92(4): 441-6.
Gerra, G., Manfredini, M., Somaini, L., Maremmani, I., Leonardi, C., Donnini, C. 2016. Sexual dysfunction in men receiving methadone maintenance treatment: clinical history and psychobiological correlates. Eur Addict Res 22(3): 163-75.
Ghowsi, M., Yousofvand, N. 2015. Impact of morphine dependency and detoxification by methadone on male’s rat reproductive System. Iran J Reprod Med 13(5): 275-82.
Giuliano, F., Chevret-Measson, M., Tsatsaris, A., Reitz, C., Murino, M., Thonneau, P. 2002. Prevalence of erectile dysfunction in France: results of an epidemiological survey of a representative sample of 1004 men. Eur Urol 42(4): 382-9.
Hallinan, R., Byrne, A., Agho, K., Mcmahon, C., Tynan, P., Attia, J. 2008. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sex Med 5(3): 684-92.
Hallinan, R., Byrne, A., Agho, K., Mcmahon, C.G., Tynan, P., Attia, J. 2009. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl 32(2): 131-9.
Joseph, H., Stancliff, S., Langrod, J. 2000. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med 67(5-6): 347-64.
Kim, M., Kim, S.Y., Rou, W.S., Hwang, S.W., Lee, B. S. 2015. Erectile dysfunction in patients with liver disease related to chronic hepatitis B. Clin Mol Hepatol 21(4): 352-7.
Krege, S., Goepel, M., Sperling, H., Michel, M. C. 2000. Affinity of trazodone for human penile alpha1- and alpha2-adrenoceptors. BJU Int 85(7): 959-61.
Kristensen, K., Christensen, C.B., Christrup, L.L. 1994. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci 56(2): 45-50.
Kupelian, V., Hall, S.A., McKinlay, J.B. 2013. Common prescription medication use and erectile dysfunction: results from the Boston Area Community Health (BACH) survey. BJU Int 112(8): 1178-87.
Lim, T.O., Das, A., Rampal, S., Zaki, M., Sahabudin, R.M., Rohan, M.J., Isaacs, S. 2003. Cross-cultural adaptation and validation of the english version of the International Index of Erectile Function (IIEF) for use in Malaysia. Int J Impot Res 15(5): 329-36.
Lugo, R.A., Satterfield, K.L., Kern, S.E. 2005. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother 19(4): 13-24.
Lugoboni, F., Zamboni, L., Federico, A., Tamburin, S. 2017. Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study. PloS One 12(11): e0188994.
Marsch, L.A. 1998. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 93(4): 515-32.
Mattick, R.P., Breen, C., Kimber, J., Davoli, M. 2009. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev (3): CD002209.
Mattick, R.P., Breen, C., Kimber, J., Davoli, M. 2014. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev (2):CD002207.
Moreira Jr, E.D., Brock, G., Glasser, D.B., Nicolosi, A., Laumann, E.O., Paik, A., Wang, T., Gingell, C., Group, G.I. 2005. Help-seeking behaviour for sexual problems: the global study of sexual attitudes and behaviors. Int J Clin Pract 59(1): 6-16.
NIH Consensus Development Panel on Impotence 1993. Impotence. In the Proceed-ings of NIH Consensus Conference: 7 July 1993; JAMA 270(1): 83-90.
Nik Jaafar, N.R., Mislan, N., Abdul Aziz, S., Baharudin, A., Ibrahim, N., Midin, M., Das, S., Sidi, H. 2013. Risk factors of erectile dysfunction in patients receiving methadone maintenance therapy. J Sex Med 10(8): 2069-76.
Parvaresh, N., Sabahi, A.R., Mazhari, S., Gilani, H. 2015. A study of the sexual function, sleep, and weight status of patients after 6 months of methadone maintenance treatment. Addict Health 7(1-2): 24.
Quaglio, G., Lugoboni, F., Pattaro, C., Melara, B., Mezzelani, P., Des Jarlais, D.C. 2008. Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug Alcohol Depend 94(1-3): 12-8.
Radfar, S.R., Cousins, S.J., Shariatirad, S., Noroozi, A., Rawson, R.A. 2016. Methamphetamine use among patients undergoing methadone maintenance treatment in Iran; a threat for harm reduction and treatment strategies: a qualitative study. Int J High Risk Behav Addict 5(4): e30327.
Ramli, F.F., Shuid, A.N., Mohamed, P., Mohamed, R., Sidik, T.A.B., Ikhwan, T.M., Naina Mohamed, I. 2019. Health-seeking behavior for erectile dysfunction in methadone maintenance treatment patients. Int J Environ Res Public Health 16(21): 4249.
Read, S., King, M., Watson, J. 1997. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med 19(4): 387-91.
Rosen, R.C., Cappelleri, J.C., Smith, M.D., Lipsky, J., Pena, B.M. 1999. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11(6): 319-26.
Rosen, R.C., Fisher, W.A., Eardley, I., Niederberger, C., Nadel, A., Sand, M. 2004. The Multinational Men’s Attitudes to Life Events and Sexuality (Males) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 20(5): 607-17.
Rosen, R.C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., Mishra, A. 1997. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49(6): 822-30.
Salehi, M., Barekatain, M., Faghani, F., Karimian, N., Molaeinezhad, M., Asadalloahi, G.A., Maracy, M.R. 2015. Bupropion efficacy on sexual dysfunction among male patients on methadone maintenance therapy: a double-blind placebo-controlled trial. Sex and Relation Ther 30(3): 364-75.
Seen Heng, Y., Sidi, H., Nik Jaafar, N.R., Razali, R., Ram, H. 2013. Phases of female sexual response cycle among Malaysian women with infertility: a factor analysis study. Asia Pac Psychiatry 5: 50-4.
Schumacher, M.A., Basbaum, A.I., Naidu, R.K. 2015. Opioid agonists & antagonists. In Basic & Clinical Pharmacology. 14th edition. Edited by Katzung BG. New York, NY: McGraw-Hill Medical. http://accessmedicine.mhmedical.com/content.aspx?bookid=2249§ionid=175220393 [6th Sept 2019]
Selvin, E., Burnett, A.L., Platz, E.A. 2007. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 120(2): 151-7.
Singh, H.H., Purohit, V., Ahluwalia, B.S. 1982. Methadone blocks dopamine-mediated release of gonadotropins in rat hypothalamus. Neuroendocrinology 34(5): 347-52.
Tabaei-Aghdaei, S.R., Babaei, A., Khosh-Khui, M., Jaimand, K., Rezaee, M.B., Assareh, M.H., Naghavi, M.R. 2007. Morphological and oil content variations amongst Damask rose (Rosa damascena Mill.) landraces from different regions of Iran. Sci Hortic 113(1): 44-8.
Tatari, F., Farnia, V., Nasiri, R.F., Najafi, F. 2010. Trazodone in methandone induced erectile dysfunction. Iran J Psychiatry 5(4): 164-6.
Tatari, F., Shakeri, J., Farnia, V., Heidari, F., Rezaei, M. 2013. Bupropion in methadone induced erectile dysfunction. Life Sci J 10(9): 330-2.
Teoh, J.B.F., Yee, A., Danaee, M., Ng, C.G., Sulaiman, A.H.B. 2017. Erectile dysfunction among patients on methadone maintenance therapy and its association with quality of life. J Addict Med 11(1): 40-6.
Ugwu, T., Ezeani, I., Onung, S., Kolawole, B., Ikem, R. 2016. Predictors of erectile dysfunction in men with type 2 diabetes mellitus referred to a tertiary healthcare centre. Adv Endocrinol 2016: 9753154
Wang, R., Ding, Y., Bai, H., Duan, S., Ye, R., Yang, Y., Wang, J., Tang, R., Gao, M., He, N. 2015. Illicit heroin and methamphetamine use among methadone maintenance treatment patients in Dehong Prefecture of Yunnan Province, China. PloS One 10(7): e0133431.
Wei, M., Macera, C.A., Davis, D.R., Hornung, C.A., Nankin, H.A., Blair, S.N. 1994. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 140(10): 930-7.
Yaksh, T., Wallace, M. 2017. Opioids, analgesia, and pain management. In Goodman & Amp; Gilman’s: The Pharmacological Basis of Therapeutics. 13th edition. Edited by Brunton LL, Hilal-Dandan R. & Knollmann BC. (pnyt.).. New York, NY: McGraw-Hill Education; http://accessmedicine.mhmedical.com/content.aspx?bookid=2189§ionid=170269577. [6th Sept 2019]
Yee, A., Loh, H.S., Danaee, M., Riahi, S., Ng, C.G., Sulaiman, A.H. 2018. Plasma testosterone and sexual function in Southeast Asian men receiving methadone and buprenorphine maintenance treatment. J Sex Med 15(2): 159-66.
Yee, A., Loh, H.S., Hashim, H.M.B.H., Ng, C. G. 2014. Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study. Int J Impot Res 26(5): 161-6.
Yee, A., Loh, H.S., Ong, T.A., Ng, C.G., Sulaiman, A. H. 2018. Randomized, double-blind, parallel-group, placebo-controlled trial of bupropion as treatment for methadone-emergent sexual dysfunction in men. Am J Mens Health 12(5): 1705-18.
Zhang, M., Zhang, H., Shi, C. X., Mcgoogan, J. M., Zhang, B., Zhao, L., Zhang, M., Rou, K., Wu, Z. 2014. Sexual dysfunction improved in heroin-dependent men after methadone maintenance treatment in Tianjin, China. PloS One 9(2): e88289.
Zhao, S., Deng, T., Luo, L., Wang, J., Li, E., Liu, L., Li, F., Luo, J., Zhao, Z. 2017. Association between opioid use and risk of erectile dysfunction: a systematic review and meta-analysis. J Sex Med 14(10): 1209-19.
